Osaic Holdings
LABT

Osaic Holdings’s Lakewood-Amedex Biotherapeutics LABT Stock Holding History

Osaic Holdings’s Portfolio LABT Stock Details LABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433 Buy
+138
New +$2.37K ﹤0.01% 7678

Other funds holding LABT

MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings's LABT Position: Q2 2026 in Review

Osaic Holdings opened a new position in Lakewood-Amedex Biotherapeutics (LABT) in Q2 2026: 138 shares worth $433. The stake represents ﹤0.01% of the portfolio and ranks #7678 among its holdings.

6 funds tracked by Wall St. Rank hold LABT as of Q2 2026.

  • Osaic Holdings held 138 shares of Lakewood-Amedex Biotherapeutics worth $433 as of Q2 2026.
  • Lakewood-Amedex Biotherapeutics was a new Osaic Holdings position in Q2 2026.
  • Lakewood-Amedex Biotherapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7678 holding.
  • 6 funds tracked by Wall St. Rank held Lakewood-Amedex Biotherapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.